Abstract CT022: CheckMate 848: A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Patients with Advanced or Metastatic Solid Tumors of High Tumor Mutational BurdenMichael Schenker,Mauricio Burotto,Martin Richardet,Tudor Ciuleanu,Anthony Goncalves,Neeltje Steeghs,Patrick Schöffski,Paolo A. Ascierto,Michele Maio,Iwona Lugowska,Lorena Lupinacci,Alexandra Leary,Jean-Pierre Delord,Julieta Grasselli,David S. Tan,Jennifer E. Friedmann,Jacqueline Vuky,Marina Tschaika,Ruta Slepetis,Georgia D. Kollia,Misena Pacius,Ning Huang,Parul Doshi,Jonathan Baden,Massimo Di NicolaCancer Research（2022）引用 14|浏览18AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
